EPISODE · Jun 7, 2016 · 11 MIN
Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016
from Listen to The Lancet Neurology · host The Lancet
Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
NOW PLAYING
Stakeholder cooperation in orphan drug development: The Lancet Neurology: June 6, 2016
0:00
11:20
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Neurology?
This episode is 11 minutes long.
When was this Listen to The Lancet Neurology episode published?
This episode was published on June 7, 2016.
What is this episode about?
Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
Can I download this Listen to The Lancet Neurology episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!